8-KFiled Aug 18, 8:00 PM ET

Jaguar Health Reports Q2 2026 Results

$JAGX · Jaguar Health, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Jaguar Health Reports Q2 2026 Results

What Happened
Jaguar Health, Inc. (JAGX) announced its financial results for the second quarter of 2026 in a press release issued August 19, 2026 and furnished that release on Form 8-K (Item 2.02). The company provided the press release as an exhibit to the filing.

Key Details

  • Filing date: August 19, 2026 (Form 8-K).
  • Item reported: 2.02 — Results of Operations and Financial Condition (press release announcing Q2 2026 results).
  • Exhibit furnished: 99.1 — Press Release dated August 19, 2026.
  • Interactive data: Exhibit 104 — Cover Page Interactive Data File (inline XBRL) embedded in the filing.

Why It Matters
Quarterly results contain key metrics investors use to assess company performance—revenue, net income/loss, cash position, and operating trends—which can affect stock value and investor decisions. This 8-K indicates Jaguar Health has publicly released its Q2 2026 earnings information; investors should read the furnished press release (Exhibit 99.1) for the specific financial figures and any management commentary or guidance.